PASW
Ping An Biomedical Co., Ltd.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R May 27 Ping An Biomedical received a Nasdaq letter on May 26, 2026, grantin…
- X Jul 15 Short interest falls 84.4% to 16.4K
- X Jul 31 Short interest jumps 415.6% to 84.8K
- X Aug 14 Short interest jumps 29.8% to 110.0K
- X Aug 31 Short interest falls 57.4% to 46.9K
- R Sep 11 Ping An Biomedical (PASW) reported H1 FY2026 results showing a sharp…
- X Sep 15 Short interest jumps 882.7% to 460.8K
- E Oct 23 Trading halt: Halt Resumed: PASW — trading resumed after LUDP (Volatilit…
Signal stack
Where each data set points today.
- Short sellersSTEADY
Short interest +6.0% to 488.3K shares. 1.0 days to cover, ≈0.4% of shares.
- TrendDOWNTREND
8% below its 50-day average. New closing low $3.68 on Oct 21.
Earnings setup
EstimatesRevision history: 🔒 Fresh data — subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data — subscribers only | |||
| Next Q | 🔒 Fresh data — subscribers only | |||
| Current FY | 🔒 Fresh data — subscribers only | |||
| Next FY | 🔒 Fresh data — subscribers only | |||
Short side
FINRA· Sep 30, 2026| Oct 23, 2026 | Volatility Pause | Resumed |
| Oct 23, 2026 | Volatility Pause | Resumed |
| Oct 23, 2026 | Volatility Pause | Resumed |
| Oct 23, 2026 | Volatility Pause | Resumed |
| Oct 23, 2026 | Volatility Pause | Resumed |
SecBot reports
7 filings · 1 press releases · 0 bullish · 3 bearish · 4 neutral- NEUTRAL 6-KOct 26, 2026
🔒 Fresh report (last 24h) — subscribers only
- BEARISH 6-KOct 22, 2026
Ping An Biomedical Co., Ltd. filed its Fourth Amended and Restated Memorandum and Articles of…
The massive authorized share increase without a concurrent business event (acquisition, financing, or restructuring) suggests the company is preparing for a large equity raise or stock-based…
- NEUTRAL PRESS RELEASEOct 22, 2026
Ping An Biomedical announced a non-binding letter of intent to acquire three oncology-related…
The deal is preliminary and non-binding with no guarantee of completion. Monitor for execution of a definitive agreement and any subsequent disclosure of final terms. Given the company's core…
- NEUTRAL 6-KOct 21, 2026
Ping An Biomedical announced a 1-for-40 reverse stock split of its class A and class B ordinary…
Reverse stock split is a mechanical adjustment with no impact on fundamentals. Monitor for potential Nasdaq compliance benefit if the split lifts the stock price above the $1 minimum bid…
All PASW filing & press-release reports (8)
- 6-K reportOct 26, 2026
- 6-K reportOct 22, 2026
- PRESS-RELEASE reportOct 22, 2026
- 6-K reportOct 21, 2026
- 6-K reportSep 11, 2026
- 6-K reportJul 20, 2026
- 6-K reportMay 27, 2026
- EFFECT reportFeb 27, 2026